Cerebral Near Infrared Spectroscopy in Out-of-Hospital Cardiac Arrest and Neurological Prognosis
Condition(s) studied
Investigational drug(s) / intervention(s)
Cerebral Near infrared spectroscopy (NIRSc).: Continuous cerebral near-infrared spectroscopy (NIRSc) during resuscitation in a patient treated for out-of-hospital cardiac arrest (OHCA).
Study summary
Out-of-hospital cardiac arrest (OHCA) prognosis remains poor : 7% of patients surviving without neurological impairment.
65% of patients dying after hospital admission were neurologically impaired. When treating a patient with CA, neurological outcome remains extremely difficult to predict, especially in the pre-hospital setting. Practitioners have very little objective information to help them with neuropronostication.
Although an EtCO2 level of \< 10 mmHg is associated with a poor neurological prognosis, European recommendations point out that this data alone is not currently sufficient to predict a patient's prognosis or to make a decision to stop resuscitation. Current recommendations do not suggest any other objective parameter during resuscitation for neuropronostication of patients with out-of-hospital cardiac arrest.
Cerebral tissue oxygen saturation (rSO2) is measured using the near infrared spectrometry (NIRS) technique. Cerebral NIRS (cNIRS) enables non-invasive measurement of changes in cerebral oximetry during the management of a cardiac arrest (CA).
Various clinical studies conducted over the last ten years have demonstrated that there is a probable link between cNIRS levels during resuscitation and return of spontaneous circulation (ROSC), but a clear threshold value has not been defined.
The aim of the NISOHCA study is to confirm that a 40% threshold of cNIRS in the pre-hospital setting for OHCA can specifically predict survival with good neurological outcome at D90 .
Eligibility
Primary outcome measure(s)
- Cerebral Performance Category (CPC) — Day 90
Specificity of predicting a 90-D survival with a good neurological outcome with a mean c-NIRS \> 40% during Cardiopulmonary Resuscitation (CPR). Cerebral Performance Category (CPC) of 1 to 5. CPC 1: Complete recovery without neurological impairment or conscious with minor impairment. CPC 5: Deceased or brain dead.
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| CH Colmar- Urgences - SAMU-SMUR | Colmar | France | |
| CHR Metz-Thionville - Mercy hospital -Urgences - SAMU-SMUR | Metz | France | |
| CHRU NANCY - urgences SAMUR SMUR- Central hospital | Nancy | France | |
| CHU Reims - ugences - SAMU-SMUR | Reims | France | |
| Hôpitaux universitaire de Strasbourg - Urgences - SAMU-SMUR | Strasbourg | France | |
| CHR Troyes- Urgences - SAMU-SMUR | Troyes | France |
More Central Hospital, Nancy, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06972329 on ClinicalTrials.gov ↗ ← All trials in France